These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 4280243
1. Serotonergic mechanisms and extrapyramidal function in man. Chase TN. Adv Neurol; 1974; 5():31-9. PubMed ID: 4280243 [No Abstract] [Full Text] [Related]
2. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes]. Buscaino GA, Mandarini A, Campanella G, Carrieri P, Orefice G. Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340 [No Abstract] [Full Text] [Related]
4. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa. Thal L, Sharpless N, Wolfson L, Engel J, Katzman R. Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459 [No Abstract] [Full Text] [Related]
5. Monoamine metabolism and depression in Parkinson patients. Puite JK, Schut T, van Praag HM, Lakke JP. Psychiatr Neurol Neurochir; 1973; 76(1):61-70. PubMed ID: 4699106 [No Abstract] [Full Text] [Related]
7. Dopaminergic nervous transmission in Parkinson's disease. Rinne UK, Sonninen V, Riekkinen P, Laaksonen H. Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255 [No Abstract] [Full Text] [Related]
8. Central monoamine metabolism in man. Effect of putative dopamine receptor agonists and antagonists. Chase TN. Arch Neurol; 1973 Nov; 29(5):349-51. PubMed ID: 4270339 [No Abstract] [Full Text] [Related]
9. Amine precursors in neurologic disorders and the psychoses. Klawans H. Res Publ Assoc Res Nerv Ment Dis; 1975 Nov; 54():259-76. PubMed ID: 130667 [No Abstract] [Full Text] [Related]
10. The probenecid test in Parkinson's disease. Lakke JP, Korf J, Hoorntje S, Schut T, van Praag HM. Psychiatr Neurol Neurochir; 1973 Nov; 76(2):139-46. PubMed ID: 4700931 [No Abstract] [Full Text] [Related]
12. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease. Altagracia M, Rojas P, Kravzov J, Rios C. Proc West Pharmacol Soc; 1993 Nov; 36():289-91. PubMed ID: 7690973 [No Abstract] [Full Text] [Related]
17. Catecholamines and neurologic diseases (second of two parts). Moskowitz MA, Wurtman RJ. N Engl J Med; 1975 Aug 14; 293(7):332-8. PubMed ID: 125386 [No Abstract] [Full Text] [Related]
18. Dopamine and extrapyramidal motor function and dysfunction. Hornykiewicz O. Res Publ Assoc Res Nerv Ment Dis; 1972 Aug 14; 50():390-415. PubMed ID: 4561070 [No Abstract] [Full Text] [Related]
19. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea. Lal S, De la Vega C, Garelis E, Sourkes TL. Psychiatr Neurol Neurochir; 1973 Aug 14; 76(2):113-7. PubMed ID: 4267059 [No Abstract] [Full Text] [Related]
20. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias). Marsden CD. Mod Trends Neurol; 1975 Aug 14; 6():141-66. PubMed ID: 127927 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]